Headlines

J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

Published by Global Banking and Finance Review

Posted on May 2, 2025

Featured image for article about Headlines

(Reuters) -HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.

The company is seeking a valuation of more than $2.5 billion, the report said.

(Reporting by Bipasha Dey in Bengaluru; Editing by Sonia Cheema)

;